These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 26207907)

  • 1. Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition.
    Serra N; Rosales R; Masana L; Vallvé JC
    PLoS One; 2015; 10(7):e0133875. PubMed ID: 26207907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
    Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
    Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels.
    Turner NA; O'Regan DJ; Ball SG; Porter KE
    FASEB J; 2005 May; 19(7):804-6. PubMed ID: 15728660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor induction by aggregated LDL depends on LDL receptor-related protein expression (LRP1) and Rho A translocation in human vascular smooth muscle cells.
    Camino-López S; Llorente-Cortés V; Sendra J; Badimon L
    Cardiovasc Res; 2007 Jan; 73(1):208-16. PubMed ID: 17141748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of Rho-associated protein kinase (ROCK) and bone morphogenetic protein-binding endothelial cell precursor-derived regulator (BMPER) in high glucose-increased alkaline phosphatase expression and activity in human coronary artery smooth muscle cells.
    Terao Y; Satomi-Kobayashi S; Hirata K; Rikitake Y
    Cardiovasc Diabetol; 2015 Aug; 14():104. PubMed ID: 26264461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells.
    Li M; Li Z; Sun X
    Eur J Pharmacol; 2008 Sep; 591(1-3):219-23. PubMed ID: 18619957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin inhibits myocardin expression in vascular smooth muscle cells.
    Li J; Jiang J; Yin H; Wang L; Tian R; Li H; Wang Z; Li D; Wang Y; Gui Y; Walsh MP; Zheng XL
    Hypertension; 2012 Jul; 60(1):145-53. PubMed ID: 22615115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
    Lee MH; Cho YS; Han YM
    Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin reduces lipoprotein-associated phospholipase A2 in lipopolysaccharide-stimulated human monocyte-derived macrophages through inhibition of the mevalonate-geranylgeranyl pyrophosphate-RhoA-p38 mitogen-activated protein kinase pathway.
    Song JX; Ren JY; Chen H
    J Cardiovasc Pharmacol; 2011 Feb; 57(2):213-22. PubMed ID: 21052011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
    Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H
    Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin ameliorates rat cerebrovascular remodeling during hypertension via inhibition of volume-regulated chloride channel.
    Liu YJ; Wang XG; Tang YB; Chen JH; Lv XF; Zhou JG; Guan YY
    Hypertension; 2010 Sep; 56(3):445-52. PubMed ID: 20644009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin attenuated cerebrovascular cell proliferation in the development of hypertension through Rho/Rho-kinase pathway.
    Ma MM; Li SY; Wang M; Guan YY
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):576-82. PubMed ID: 22392066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation by simvastatin of iberiotoxin-sensitive, Ca2+-activated K+ channels of porcine coronary artery smooth muscle cells.
    Seto SW; Au AL; Lam TY; Chim SS; Lee SM; Wan S; Tjiu DC; Shigemura N; Yim AP; Chan SW; Tsui SK; Leung GP; Kwan YW
    Br J Pharmacol; 2007 Aug; 151(7):987-97. PubMed ID: 17558433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Hydroxymethyl coenzyme A reductase inhibition attenuates spontaneous smooth muscle tone via RhoA/ROCK pathway regulated by RhoA prenylation.
    Rattan S
    Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G962-9. PubMed ID: 20378830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin inhibits glucose-stimulated vascular smooth muscle cell migration involving increased expression of RhoB and a block of Ras/Akt signal.
    Chan KC; Wu CH; Huang CN; Lan KP; Chang WC; Wang CJ
    Cardiovasc Ther; 2012 Apr; 30(2):75-84. PubMed ID: 20946258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of G protein-coupled estrogen receptor 1 induces coronary artery relaxation via Epac/Rap1-mediated inhibition of RhoA/Rho kinase pathway in parallel with PKA.
    Yu X; Zhang Q; Zhao Y; Schwarz BJ; Stallone JN; Heaps CL; Han G
    PLoS One; 2017; 12(3):e0173085. PubMed ID: 28278256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-methoxyestradiol inhibits atorvastatin-induced rounding of human vascular smooth muscle cells.
    Yin H; Gui Y; Zheng XL
    J Cell Physiol; 2010 Mar; 222(3):556-64. PubMed ID: 19937728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of HMG-CoA Reductase Inhibition on Vascular Smooth Muscle Cells Extracellular Matrix Production: Role of RhoA.
    Palomino-Morales R; Perales S; Torres C; Linares A; Alejandre MJ
    Curr Vasc Pharmacol; 2016; 14(4):345-52. PubMed ID: 26924327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.